Iron Homeostasis and Fetoplacental Regulatory Mechanisms

Metabolic Requirements and Placental Transport

The rapid expansion of maternal red blood cell mass and the demands of fetal morphogenesis lead to an exponential increase in iron requirements.

While an adult woman has basal body reserves of nearly two grams, a growing adolescent accumulates barely half of this amount.

During early pregnancy, this deficit is exacerbated if the intervals between pregnancies are short.

In this scenario, the placenta acts as a regulatory organ of active extraction: the syncytiotrophoblast overexpresses transferrin receptors on its microvillus membrane to capture serum iron via endocytosis and transfer it unidirectionally into the fetal circulation.

This biological prioritization ensures intrauterine development but subjects the young pregnant woman to rapid depletion of her tissue reserves and an imminent risk of hematological decompensation.

Laboratory Diagnosis, Dietary Inhibitors, and Replacement Therapy

The progression of the deficiency begins with subtle neuropsychiatric changes (irritability, mental asthenia), followed by tissue changes such as brittle nails, glossitis, or pica, before the classic anemic syndrome becomes established.

A definitive diagnosis is based on hematological parameters, identifying microcytic anemia through a decrease in mean corpuscular volume (MCV) and an elevated red blood cell distribution width (RDW).

Serum ferritin is the gold standard for quantifying tissue depletion.

Therapeutic management requires education about interfering factors: phytates, tannins, and calcium block the enteral absorption of the mineral, requiring that doses be taken separately from inhibitory foods and combined with ascorbic acid.

In established deficiencies, oral or intravenous administration of the medication should be continued for three to six months to ensure complete replenishment of body stores.